Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date

As antimicrobial resistance continues to grow, one of the biggest threats includes the members of the Enterobacterales order presenting with carbapenem resistance (CRE). Meropenem-vaborbactam, along with other beta-lactam/beta-lactamase agents, has been developed to help combat this growing concern...

Descripción completa

Detalles Bibliográficos
Autores principales: Herald, Fischer, Burgos, Rodrigo M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885963/
https://www.ncbi.nlm.nih.gov/pubmed/36726388
http://dx.doi.org/10.2147/IDR.S187360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885963/
https://www.ncbi.nlm.nih.gov/pubmed/36726388
http://dx.doi.org/10.2147/IDR.S187360

Ejemplares similares